IBD-RESPONSE – predicting treatment response in Crohn’s disease and ulcerative colitis
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, causes painful bowel symptoms and tiredness. Powerful treatments known as biologics and advanced therapies can calm gut inflammation. However, up to 40% of people find these drugs do not work well for them. Currently, doctors cannot easily predict who will benefit most. The IBD-RESPONSE study is an observational project taking place across 40 NHS hospitals in the UK. It aims to find out if the tiny bacteria living naturally in the gut can tell us which treatment is best for each person. Taking part does not change your planned NHS care. If you are 16 or over and starting an advanced treatment, you can join by collecting stool samples at home, providing routine blood samples, and filling in short questionnaires. This research will help create personalised care for people living with IBD.
At a glance
What is this study about?
Crohn’s disease and ulcerative colitis are long-term conditions that cause painful inflammation in the digestive system. Common symptoms like frequent diarrhoea, stomach cramps, and severe fatigue can make daily life challenging. To help manage these conditions, NHS specialists often prescribe powerful medicines called biologics or targeted therapies. While these treatments can be life-changing, they do not work for everyone, and it is currently impossible to know in advance who will benefit.
Scientists now believe that the trillions of tiny bugs living in our digestive tract, known as the gut microbiome, might hold the answer. Small studies suggest that the types of bacteria present in your bowel may influence how your body handles medication. The IBD-RESPONSE study is designed to explore this link in detail by following 1,325 patients across the UK as they begin their treatment.
Because this is an observational study, it does not involve testing any new or unapproved medications. Instead, researchers simply look closely at your gut bacteria, genes, and diet alongside the routine medication your own doctor has already chosen for you.
By comparing the samples of people who get better with those who do not, the research team hopes to build a reliable test. In the future, this could allow doctors to match every patient with the right medicine straight away, avoiding unnecessary side effects and helping people feel better much faster.
Key takeaways
- A large UK observational study across 40 NHS hospitals studying Crohn’s and colitis.
- Investigates whether gut bacteria can show which patients will respond to advanced medications.
- Does not give you any experimental drugs; you receive your doctor's recommended treatment.
- Involves simple home stool samples, routine blood tests, and lifestyle questionnaires.
- Aims to make future IBD treatments faster, safer, and tailored to the individual.
Who may be eligible?
This study is open to adults and young people aged 16 and over who have a confirmed diagnosis of Crohn's disease, ulcerative colitis, or unclassified inflammatory bowel disease (IBD-U).
To be eligible, your NHS specialist must already be planning to start you on a specific biologic or advanced medicine (such as infliximab, adalimumab, vedolizumab, ustekinumab, a JAK inhibitor, or ozanimod) to treat active inflammation.
You will also need recent test results—from within the last 16 weeks—showing that your disease is currently active. This could be a high stool inflammation score (calprotectin of 250 or above), raised blood markers (CRP of 6 or above), or visible inflammation on a recent camera test (endoscopy) or scan.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 16 or over.
- I have a confirmed diagnosis of Crohn's disease, ulcerative colitis, or IBD-U.
- My specialist is about to start me on a biologic or advanced targeted treatment.
- I have had recent tests (within 16 weeks) showing active gut inflammation.
- I am willing to collect stool samples at home and complete short questionnaires.
What does participation involve?
Taking part in this study is designed to fit around your regular NHS appointments. Because this is an observational study, you will take the exact medication your own hospital doctor prescribes, with no experimental drugs involved.
You will be asked to collect stool samples at home using simple kits provided by the team, both before you start treatment and at set times during your therapy. When you visit the hospital for your usual check-ups, the team will take small routine blood samples and ask you to complete short questionnaires about your symptoms and diet. If you happen to have a planned camera examination (endoscopy) as part of your normal care, the doctor may take a few tiny tissue samples (biopsies) for the study. You will be followed up during your first year of treatment, and the overall study runs until late 2026.
Potential risks and benefits
Locations (44)
- Freeman HospitalApproximateNewcastle, England
- Royal Devon and Exeter HospitalCity onlyExeter, England
- St Thomas's HospitalApproximateLondon, England
- NHS LothianApproximateEdinburgh, Scotland
- The Royal London HospitalApproximateLondon, England
- St. Mary's HospitalUnverifiedLondon, England
- John Radcliffe HospitalUnverifiedOxford, England
- Hull Royal InfirmaryUnverifiedHull, England
- Lister HospitalUnverifiedStevenage, England
- New Cross HospitalUnverifiedWolverhampton, England
- Royal Liverpool University HospitalUnverifiedLiverpool, England
- Kettering General Hospital NHS Foundation TrustUnverifiedKettering, England
Common questions
Will taking part change which medication I receive?
No. Your NHS specialist will choose and prescribe your treatment as normal. The study simply monitors how well that treatment works for you.
Do I have to undergo an extra endoscopy (camera test)?
No. Biopsies are only collected if you are already having a planned camera test as part of your standard NHS care.
How do I collect stool samples at home?
The study team will provide you with clear instructions and easy-to-use, hygienic collection kits that you can complete in your own bathroom.
Will this study require lots of extra hospital visits?
No. Study activities, like blood tests, are arranged to match up with your routine hospital check-ups and treatment visits.
What happens if I change my mind later on?
You can leave the study at any time without giving a reason. Your doctors will continue to give you the best possible NHS care.
How to find out more
Victoria Hildreth
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.